A series of dihydropyrrol-2-ones
(DHPs) were designed and synthesized
via an efficient multicomponent reaction at room temperature for evaluation
of their bioactivities against four human cancer lines (MCF-7, RKO,
HeLa, and A549) in vitro. Preliminary structure–activity relationship
studies showed that R4 = 3-MeO-4-OH-Ph is a crucial group
for increasing cytotoxicities against RKO cells and the influences
of R1–R3 depend on their combination.
It was found that DHPs 5a, 5q, and 5s showed the best antiproliferative activities against A549,
RKO, and all four studied cell lines, respectively (IC50 = 1.9, 0.8, and 0.9–2.4 μM). They can be used as new
lead compounds for developing potentially selective or broad spectrum
anticancer agents. 5q proves as a potent G0/G1-phase
arresting agent inducing cell apoptosis by increasing/decreasing the
levels of p53 and p21/cyclin D1.